Zhende Medical Co., Ltd. (SHA:603301)

Market Cap	23.47B +328.1%
Revenue (ttm)	4.34B +1.1%
Net Income	264.02M -27.3%
EPS	1.00 -26.3%
Shares Out	263.75M
PE Ratio	89.02
Forward PE	47.85
Dividend	0.30 (0.34%)
Ex-Dividend Date	Jun 18, 2026

Volume	2,105,731
Open	88.10
Previous Close	88.15
Day's Range	86.51 - 89.30
52-Week Range	19.81 - 104.84
Beta	0.46
Analysts	Strong Buy
Price Target	25.00 (-71.91%)
Earnings Date	Aug 28, 2026

About Zhende Medical

Zhende Medical Co., Ltd. engages in the research and development, production, and sale of medical care and protective equipment in China and internationally. The company offers gauze swab, lap sponge, and fluff gauze swab; non-woven swab; PBT bandage, elastic bandage, crepe bandage, crochet bandage, selvedge bandage, under-cast padding, and fluff gauze roll; dressing set; first aid kit; cotton pad and applicator; and gauze roll and abdominal pad. It also provides surgical gown, scrub suit, warm-up jacket, surgical headwear, and isolation gown; ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1994
• Employees: 7,909
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603301

Financial Performance

In 2025, Zhende Medical's revenue was 4.33 billion, an increase of 1.54% compared to the previous year's 4.26 billion. Earnings were 260.82 million, a decrease of -32.29%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 18, 2026

Data Sources Report a data error